Charles Gayer

Chief Commercial Officer

Other CEO Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Biocryst Pharmaceuticals Inc (BCRX)	President and Chief Executive Officer; Former Chief Commercial Officer	$609,397	—	$3,358,230	$4,893,653	$749,088	$17,500	$9,627,868
2024	Biocryst Pharmaceuticals Inc (BCRX)	Chief Commercial Officer	$544,830	—	$930,771	$1,392,012	$490,347	$17,250	$3,375,210
2023	Biocryst Pharmaceuticals Inc (BCRX)	Chief Commercial Officer	$495,300	—	$218,620	$725,803	$282,321	$16,500	$1,738,544
2022	Biocryst Pharmaceuticals Inc (BCRX)	Chief Commercial Officer	$448,700	—	$361,420	$1,194,012	$179,480	$15,250	$2,198,862

Earnings-call appearances

Biocryst Pharmaceuticals Inc Q3 FY2025 Earnings Call
Biocryst Pharmaceuticals Inc (BCRX)

2025-10-14
Biocryst Pharmaceuticals Inc Q2 FY2025 Earnings Call
Biocryst Pharmaceuticals Inc (BCRX)

2025-08-04
Biocryst Pharmaceuticals Inc Q2 FY2022 Earnings Call
Biocryst Pharmaceuticals Inc (BCRX)

2022-08-04
Biocryst Pharmaceuticals Inc Q1 FY2021 Earnings Call
Biocryst Pharmaceuticals Inc (BCRX)

2021-05-06
Biocryst Pharmaceuticals Inc Q3 FY2020 Earnings Call
Biocryst Pharmaceuticals Inc (BCRX)

2020-11-05